- Home
- IMMP vs IMMR Comparison
IMMP vs IMMR Comparison
Compare IMMP & IMMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- IMMR
- Stock Information
- Founded
- IMMP 1987
- IMMR 1993
- Country
- IMMP Australia
- IMMR United States
- Employees
- IMMP N/A
- IMMR N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- IMMR Computer peripheral equipment
- Sector
- IMMP Health Care
- IMMR Technology
- Exchange
- IMMP Nasdaq
- IMMR Nasdaq
- Market Cap
- IMMP 304.0M
- IMMR 272.7M
- IPO Year
- IMMP N/A
- IMMR 1999
- Fundamental
- Price
- IMMP $1.92
- IMMR $8.48
- Analyst Decision
- IMMP Buy
- IMMR Strong Buy
- Analyst Count
- IMMP 2
- IMMR 1
- Target Price
- IMMP $8.50
- IMMR $13.50
- AVG Volume (30 Days)
- IMMP 72.2K
- IMMR 405.1K
- Earning Date
- IMMP 03-03-2025
- IMMR 03-06-2025
- Dividend Yield
- IMMP N/A
- IMMR 4.48%
- EPS Growth
- IMMP N/A
- IMMR 57.07
- EPS
- IMMP N/A
- IMMR 2.04
- Revenue
- IMMP $2,563,302.00
- IMMR $163,133,000.00
- Revenue This Year
- IMMP N/A
- IMMR $988.71
- Revenue Next Year
- IMMP $47.79
- IMMR $288.32
- P/E Ratio
- IMMP N/A
- IMMR $4.15
- Revenue Growth
- IMMP 9.59
- IMMR 338.21
- 52 Week Low
- IMMP $1.66
- IMMR $6.54
- 52 Week High
- IMMP $3.34
- IMMR $13.94
- Technical
- Relative Strength Index (RSI)
- IMMP 43.56
- IMMR 48.21
- Support Level
- IMMP $1.94
- IMMR $8.14
- Resistance Level
- IMMP $2.08
- IMMR $8.80
- Average True Range (ATR)
- IMMP 0.08
- IMMR 0.24
- MACD
- IMMP -0.00
- IMMR 0.04
- Stochastic Oscillator
- IMMP 20.00
- IMMR 57.79
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About IMMR Immersion Corporation
Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.